Antibody-mediated neutralization of SARS-CoV-2-Reference-Cited by-同舟云学术

Antibody-mediated neutralization of SARS-CoV-2

Published:2022-06 Issue:6 Volume:55 Page:925-944
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Gruell Henning,Vanshylla Kanika,Weber Timm,Barnes Christopher O.,Kreer Christoph,Klein Florian^ORCID

Funder

Deutsche Forschungsgemeinschaft

BMBF Bonn

Howard Hughes Medical Institute

Universität zu Köln

Deutsches Zentrum für Infektionsforschung

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference295 articles.

1. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar;Abu-Raddad;N. Engl. J. Med.,2022

2. Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar;Abu-Raddad;N. Engl. J. Med.,2022

3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial;Lancet Infect. Dis.,2021

4. Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: a randomized controlled trial;Ann. Intern. Med.,2022

5. A neutralizing monoclonal antibody for hospitalized patients with covid-19;N. Engl. J. Med.,2021

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance evaluation of four kits for the detection of neutralizing antibody against SARS-CoV-2 in human serum;Journal of Clinical Virology Plus;2024-09

2. Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period;Cellular and Molecular Life Sciences;2024-08-22

3. Protective non-neutralizing SARS-CoV-2 monoclonal antibodies;Trends in Immunology;2024-08

4. Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: A longitudinal community-based population study in China;International Journal of Infectious Diseases;2024-08

5. The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies;MedComm;2024-07-29